{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:11:30Z","timestamp":1793502690946,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Association of the Integration of Traditional Chinese and Western Medicine","award":["No. ZXY2025010"],"award-info":[{"award-number":["No. ZXY2025010"]}]},{"name":"Municipal Key Science and Technology Program of Leshan","award":["No. 24ZDYF0098"],"award-info":[{"award-number":["No. 24ZDYF0098"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Association","award":["YCH-KY-YCZD2024-135"],"award-info":[{"award-number":["YCH-KY-YCZD2024-135"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01092-5","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T02:55:21Z","timestamp":1769568921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decrypting potential mechanisms linking ochratoxin A to hepatocellular carcinoma: an integrated approach combining toxicology, machine learning, molecular docking, and molecular dynamics simulation"],"prefix":"10.1186","volume":"27","author":[{"given":"Junyi","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"6","key":"1092_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021.","journal-title":"J Hepatol"},{"key":"1092_CR2","doi-asserted-by":"publisher","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries. CA Cancer J Clin. 2021; 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"issue":"1","key":"1092_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41256-025-00416-y","volume":"10","author":"J Liu","year":"2025","unstructured":"Liu J, et al. The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the global burden of disease study 2021. Glob Health Res Policy. 2025;10(1):22. https:\/\/doi.org\/10.1186\/s41256-025-00416-y.","journal-title":"Glob Health Res Policy"},{"issue":"19","key":"1092_CR4","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1097\/cm9.0000000000003264","volume":"137","author":"Q Li","year":"2024","unstructured":"Li Q, et al. Global epidemiology of liver cancer 2022: an emphasis on geographic disparities. Chin Med J (Engl). 2024;137(19):2334\u201342. https:\/\/doi.org\/10.1097\/cm9.0000000000003264.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"1092_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3350\/cmh.2022.0316","volume":"29","author":"S Choi","year":"2023","unstructured":"Choi S, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990\u20132019: A DALY-based analysis of the global burden of disease 2019 study. Clin Mol Hepatol. 2023;29(2):433\u201352. https:\/\/doi.org\/10.3350\/cmh.2022.0316.","journal-title":"Clin Mol Hepatol"},{"key":"1092_CR6","doi-asserted-by":"publisher","unstructured":"Wild CP, et al. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 2010;31(1):71\u201382 https:\/\/doi.org\/10.1093\/carcin\/bgp264","DOI":"10.1093\/carcin\/bgp264"},{"issue":"24","key":"1092_CR7","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.3748\/wjg.v19.i24.3723","volume":"19","author":"RJ Felizardo","year":"2013","unstructured":"Felizardo RJ, et al. Hepatocellular carcinoma and food contamination: aflatoxins and Ochratoxin A as a great prompter. World J Gastroenterol. 2013;19(24):3723\u20135. https:\/\/doi.org\/10.3748\/wjg.v19.i24.3723.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"1092_CR8","first-page":"95","volume":"16","author":"WL Bryden","year":"2007","unstructured":"Bryden WL. Mycotoxins in the food chain: human health implications.Asia Pac. J Clin Nutr. 2007;16(Suppl 1):95\u2013101.","journal-title":"J Clin Nutr"},{"issue":"8","key":"1092_CR9","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1080\/10408398.2022.2121910","volume":"64","author":"C Song","year":"2024","unstructured":"Song C, et al. Mechanisms and transformed products of aflatoxin B1 degradation under multiple treatments: a review. Crit Rev Food Sci Nutr. 2024;64(8):2263\u201375. https:\/\/doi.org\/10.1080\/10408398.2022.2121910.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"8","key":"1092_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/s1470-2045(21)00279-5","volume":"22","author":"H Rumgay","year":"2021","unstructured":"Rumgay H, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021;22(8):1071\u201380. https:\/\/doi.org\/10.1016\/s1470-2045(21)00279-5.","journal-title":"Lancet Oncol"},{"key":"1092_CR11","doi-asserted-by":"publisher","unstructured":"Heussner AH, et al. Comparative Ochratoxin toxicity: A review of the available data. Toxins (Basel). 2015;7(10):4253\u201382. https:\/\/doi.org\/10.3390\/toxins7104253.","DOI":"10.3390\/toxins7104253"},{"issue":"5","key":"1092_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0031-9422(01)00316-8","volume":"58","author":"Harris","year":"2001","unstructured":"Harris JP, et al. Biosynthesis of ochratoxins by Aspergillus ochraceus. Phytochemistry. 2001;58(5):709\u201316. https:\/\/doi.org\/10.1016\/s0031-9422(01)00316-8.","journal-title":"Phytochemistry"},{"issue":"4","key":"1092_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/toxins2040461","volume":"2","author":"A el Khoury","year":"2010","unstructured":"el Khoury A, et al. Ochratoxin a: general overview and actual molecular status. Toxins (Basel). 2010;2(4):461\u201393. https:\/\/doi.org\/10.3390\/toxins2040461.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"1092_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mnfr.200600137","volume":"51","author":"A Pfohl-Leszkowicz","year":"2007","unstructured":"Pfohl-Leszkowicz A, Ochratoxin A, et al. An overview on toxicity and carcinogenicity in animals and humans.Mol. Nutr Food Res. 2007;51(1):61\u201399. https:\/\/doi.org\/10.1002\/mnfr.200600137.","journal-title":"Nutr Food Res"},{"issue":"3","key":"1092_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0301-6226(02)00124-0","volume":"76","author":"E Petzinger","year":"2002","unstructured":"Petzinger E, et al. Mycotoxins in the food chain: the role of ochratoxins. Livest Prod Sci. 2002;76(3):245\u201350. https:\/\/doi.org\/10.1016\/s0301-6226(02)00124-0.","journal-title":"Livest Prod Sci"},{"key":"1092_CR16","doi-asserted-by":"publisher","unstructured":"Tao Y, Ochratoxin A, et al. Toxicity, oxidative stress and metabolism. Food chem toxicol. 2018;112:320\u201331 https:\/\/doi.org\/10.1016\/j.fct.2018.01.002","DOI":"10.1016\/j.fct.2018.01.002"},{"key":"1092_CR17","doi-asserted-by":"publisher","unstructured":"Shin HS et al. Ochratoxin A-induced hepatotoxicity through phase I and phase II reactions regulated by AhR in liver cells. Toxins (Basel). 2019;11(7). https:\/\/doi.org\/10.3390\/toxins11070377","DOI":"10.3390\/toxins11070377"},{"key":"1092_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep05163","author":"XZ Qi","year":"2014","unstructured":"Qi XZ, et al. Ochratoxin A induced early hepatotoxicity: new mechanistic insights from microRNA, mRNA and proteomic profiling studies. Sci Rep. 2014. https:\/\/doi.org\/10.1038\/srep05163.","journal-title":"Sci Rep"},{"key":"1092_CR19","doi-asserted-by":"publisher","first-page":"109324","DOI":"10.1016\/j.envint.2025.109324","volume":"196","author":"M Cheng","year":"2025","unstructured":"Cheng M, et al. Exploring the mechanism of PPCPs on human metabolic diseases based on network toxicology and molecular Docking. Environ Int. 2025;196:109324. https:\/\/doi.org\/10.1016\/j.envint.2025.109324.","journal-title":"Environ Int"},{"issue":"7","key":"1092_CR20","doi-asserted-by":"publisher","first-page":"9399","DOI":"10.1007\/s12035-025-04857-x","volume":"62","author":"B Yan","year":"2025","unstructured":"Yan B, et al. Identification of key fatty acid Metabolism-Related genes in alzheimer\u2019s disease. Mol Neurobiol. 2025;62(7):9399\u2013415. https:\/\/doi.org\/10.1007\/s12035-025-04857-x.","journal-title":"Mol Neurobiol"},{"key":"1092_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad965","author":"E Clough","year":"2024","unstructured":"Clough E, et al. NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update. Acids Res. 2024;52(D1):D138\u201344. https:\/\/doi.org\/10.1093\/nar\/gkad965"},{"issue":"7","key":"1092_CR22","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1097\/js9.0000000000002455","volume":"111","author":"J Gao","year":"2025","unstructured":"Gao J, et al. Integrating machine learning and molecular Docking to Decipher the molecular network of aflatoxin B1-induced hepatocellular carcinoma. Int J Surg. 2025;111(7):4539\u201349. https:\/\/doi.org\/10.1097\/js9.0000000000002455.","journal-title":"Int J Surg"},{"key":"1092_CR23","doi-asserted-by":"publisher","unstructured":"Lim H-Y, et al. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Annals of Surgical Oncology. 2013;20(12):3747\u201353 https:\/\/doi.org\/10.1245\/s10434-013-3070-y","DOI":"10.1245\/s10434-013-3070-y"},{"issue":"1","key":"1092_CR24","first-page":"50","volume":"1739","author":"B-Y Kim","year":"2004","unstructured":"Kim B-Y, et al. Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarray.Biochimica. Et Biophys Acta. 2004;1739(1):50\u201361.","journal-title":"Et Biophys Acta"},{"issue":"5","key":"1092_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gutjnl-2014-308483","volume":"65","author":"E Villa","year":"2015","unstructured":"Villa E, et al. Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. Gut. 2015;65(5):861\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2014-308483.","journal-title":"Gut"},{"key":"1092_CR26","doi-asserted-by":"publisher","unstructured":"Grinchuk OV, et al. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. Mol Oncol. 2017; 12(1). https:\/\/doi.org\/10.1002\/1878-0261.12153","DOI":"10.1002\/1878-0261.12153"},{"issue":"7","key":"1092_CR27","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"W-K Sung","year":"2012","unstructured":"Sung W-K, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012;44(7):765\u20139. https:\/\/doi.org\/10.1038\/ng.2295.","journal-title":"Nat Genet"},{"issue":"7","key":"1092_CR28","doi-asserted-by":"publisher","first-page":"e20090","DOI":"10.1371\/journal.pone.0020090","volume":"6","author":"JR Lamb","year":"2011","unstructured":"Lamb JR, et al. Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and May rate limiting. PLoS ONE. 2011;6(7):e20090. https:\/\/doi.org\/10.1371\/journal.pone.0020090.","journal-title":"PLoS ONE"},{"issue":"W1","key":"1092_CR29","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45(W1):W356. https:\/\/doi.org\/10.1093\/nar\/gkx374.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1092_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1021\/acs.jcim.5b00690","volume":"56","author":"X Wang","year":"2016","unstructured":"Wang X, et al. Enhancing the enrichment of Pharmacophore-Based target prediction for the polypharmacological profiles of drugs. J Chem Inf Model. 2016;56(6):1175\u201383. https:\/\/doi.org\/10.1021\/acs.jcim.5b00690.","journal-title":"J Chem Inf Model"},{"key":"1092_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq300","author":"X Liu","year":"2010","unstructured":"Liu X, et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res. 2010. https:\/\/doi.org\/10.1093\/nar\/gkq300. 38(Web Server issue). W609-W.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"1092_CR32","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 2024;52(W1):W422\u201331. https:\/\/doi.org\/10.1093\/nar\/gkae236.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"1092_CR33","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, et al. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2024;52(W1):W513\u201320. https:\/\/doi.org\/10.1093\/nar\/gkae303.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1092_CR34","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"1092_CR35","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. CB-Dock2: improved protein-ligand blind Docking by integrating cavity detection, Docking and homologous template fitting. Nucleic Acids Res. 2022;50(W1):W159. https:\/\/doi.org\/10.1093\/nar\/gkac394.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"1092_CR36","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701\u201318.","journal-title":"J Comput Chem"},{"key":"1092_CR37","doi-asserted-by":"publisher","unstructured":"Filipe HAL, et al. Molecular dynamics simulations: advances and applications. Molecules. 2022;27(7). https:\/\/doi.org\/10.3390\/molecules27072105","DOI":"10.3390\/molecules27072105"},{"issue":"1","key":"1092_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40104-023-00912-6","volume":"14","author":"W Ma","year":"2023","unstructured":"Ma W, et al. Ochratoxin A induces abnormal Tryptophan metabolism in the intestine and liver to activate AMPK signaling pathway. J Anim Sci Biotechnol. 2023;14(1):125. https:\/\/doi.org\/10.1186\/s40104-023-00912-6.","journal-title":"J Anim Sci Biotechnol"},{"issue":"8","key":"1092_CR39","doi-asserted-by":"publisher","first-page":"e13641","DOI":"10.1111\/cpr.13641","volume":"57","author":"L Grisetti","year":"2024","unstructured":"Grisetti L, et al. The role of Aurora kinase A in hepatocellular carcinoma: unveiling the intriguing functions of a key but still underexplored factor in liver cancer. Cell Prolif. 2024;57(8):e13641. https:\/\/doi.org\/10.1111\/cpr.13641.","journal-title":"Cell Prolif"},{"issue":"1","key":"1092_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, et al. Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer. 2021;20(1):15. https:\/\/doi.org\/10.1186\/s12943-020-01305-3.","journal-title":"Mol Cancer"},{"issue":"7","key":"1092_CR41","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nm.4107","volume":"22","author":"D Dauch","year":"2016","unstructured":"Dauch D, et al. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer. Nat Med. 2016;22(7):744\u201353. https:\/\/doi.org\/10.1038\/nm.4107.","journal-title":"Nat Med"},{"key":"1092_CR42","doi-asserted-by":"publisher","unstructured":"Hu K, et al. PARP\u20131 in liver diseases: molecular mechanisms, therapeutic potential and emerging clinical applications (Review). Mol Med Rep. 2025;32(6). https:\/\/doi.org\/10.3892\/mmr.2025.13689.","DOI":"10.3892\/mmr.2025.13689"},{"issue":"1","key":"1092_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-021-01315-9","volume":"20","author":"XD Yang","year":"2021","unstructured":"Yang XD, et al. PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma. Mol Cancer. 2021;20(1):20. https:\/\/doi.org\/10.1186\/s12943-021-01315-9.","journal-title":"Mol Cancer"},{"issue":"1","key":"1092_CR44","doi-asserted-by":"publisher","first-page":"011503","DOI":"10.1063\/5.0082656","volume":"6","author":"A Vahabikashi","year":"2022","unstructured":"Vahabikashi A, et al. Nuclear lamins: structure and function in mechanobiology. APL Bioeng. 2022;6(1):011503. https:\/\/doi.org\/10.1063\/5.0082656.","journal-title":"APL Bioeng"},{"issue":"20","key":"1092_CR45","doi-asserted-by":"publisher","first-page":"12008","DOI":"10.1111\/jcmm.15829","volume":"24","author":"H Liu","year":"2020","unstructured":"Liu H, et al. LMNA functions as an oncogene in hepatocellular carcinoma by regulating the proliferation and migration ability. J Cell Mol Med. 2020;24(20):12008\u201319. https:\/\/doi.org\/10.1111\/jcmm.15829.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1092_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/15548627.2020.1749367","volume":"17","author":"M Jacquet","year":"2021","unstructured":"Jacquet M, et al. The functions of Atg8-family proteins in autophagy and cancer: linked or unrelated? Autophagy. 2021;17(3):599\u2013611. https:\/\/doi.org\/10.1080\/15548627.2020.1749367.","journal-title":"Autophagy"},{"key":"1092_CR47","doi-asserted-by":"publisher","unstructured":"Boyer-Guittaut M, et al. The role of GABARAPL1\/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells. Autophagy. 2014;10(6):986\u20131003 https:\/\/doi.org\/10.4161\/auto.28390","DOI":"10.4161\/auto.28390"},{"issue":"5","key":"1092_CR48","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3892\/or.2014.3096","volume":"31","author":"C Liu","year":"2014","unstructured":"Liu C, et al. Low expression of GABARAPL1 is associated with a poor outcome for patients with hepatocellular carcinoma. Oncol Rep. 2014;31(5):2043\u20138. https:\/\/doi.org\/10.3892\/or.2014.3096.","journal-title":"Oncol Rep"},{"issue":"2\u20133","key":"1092_CR49","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.mam.2012.07.010","volume":"34","author":"Anderson","year":"2013","unstructured":"Anderson CM, et al. SLC27 fatty acid transport proteins. Mol Aspects Med. 2013;34(2\u20133):516\u201328. https:\/\/doi.org\/10.1016\/j.mam.2012.07.010.","journal-title":"Mol Aspects Med"},{"issue":"2","key":"1092_CR50","doi-asserted-by":"publisher","first-page":"e2304408","DOI":"10.1002\/advs.202304408","volume":"11","author":"K Wu","year":"2024","unstructured":"Wu K, et al. Loss of SLC27A5 activates hepatic stellate cells and promotes liver fibrosis via unconjugated cholic acid. Adv Sci (Weinh). 2024;11(2):e2304408. https:\/\/doi.org\/10.1002\/advs.202304408.","journal-title":"Adv Sci (Weinh)"},{"key":"1092_CR51","doi-asserted-by":"publisher","unstructured":"Wang MD et al. Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway. Oncogenesis. 2021;10(11):74 https:\/\/doi.org\/10.1038\/s41389-021-00364-5","DOI":"10.1038\/s41389-021-00364-5"},{"key":"1092_CR52","doi-asserted-by":"publisher","unstructured":"Gautheron J, et al. The multifaceted role of epoxide hydrolases in human health and Disease.Int. J Mol Sci. 2020;22(1). https:\/\/doi.org\/10.3390\/ijms22010013.","DOI":"10.3390\/ijms22010013"},{"key":"1092_CR53","doi-asserted-by":"publisher","unstructured":"Zhan K, et al. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma. Mol Med Rep. 2021;24(3). https:\/\/doi.org\/10.3892\/mmr.2021.12289.","DOI":"10.3892\/mmr.2021.12289"},{"issue":"14","key":"1092_CR54","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.3748\/wjg.v21.i14.4310","volume":"21","author":"K Qu","year":"2015","unstructured":"Qu K, et al. Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients. World J Gastroenterol. 2015;21(14):4310\u201322. https:\/\/doi.org\/10.3748\/wjg.v21.i14.4310.","journal-title":"World J Gastroenterol"},{"key":"1092_CR55","doi-asserted-by":"publisher","unstructured":"Wi\u0119ckowska M et al. Ochratoxin A-The current knowledge concerning hepatotoxicity, mode of action and possible Prevention. Molecules. 2023;28(18). https:\/\/doi.org\/10.3390\/molecules28186617","DOI":"10.3390\/molecules28186617"},{"issue":"4","key":"1092_CR56","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.clinbiochem.2006.01.008","volume":"39","author":"J Wang","year":"2006","unstructured":"Wang J, et al. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clin Biochem. 2006;39(4):344\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.01.008.","journal-title":"Clin Biochem"},{"key":"1092_CR57","doi-asserted-by":"publisher","unstructured":"Marin JJG, et al. Models for understanding resistance to chemotherapy in liver cancer. Cancers (Basel). 2019;11(11). https:\/\/doi.org\/10.3390\/cancers11111677","DOI":"10.3390\/cancers11111677"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01092-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:06:01Z","timestamp":1771596361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01092-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01092-5","relation":{"references":[{"id-type":"doi","id":"10.1093\/nar\/gkad965","asserted-by":"subject"}]},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication."}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}